A 45-year-old woman has been referred to the High Dependency Unit from the Emergency department for haemodynamic monitoring following an episode of hypotension, which has responded to 3L fluid resuscitation.
She had presented with one day of worsening malaise and myalgia on a background of having just completed a six week course of intravenous flucloxacillin for osteomyelitis of her left foot administered through a peripherally inserted central line (PICC). Examination in the emergency department revealed that she was febrile (38.5oC), tachycardiac (120 bpm) and hypotensive (90/60mmHg) but otherwise was unremarkable. The PICC is still in situ.
Initial investigations:
|
Normal Range |
||
|
Hb |
130 g/L |
115-160 |
|
WCC |
24 x10^9/L |
4.0-11.0 |
|
Neut |
20 x10^9/L |
1.8-7.5 |
|
Plat |
200 x10^9/L |
150-400 |
|
Urea |
6.4 mmol/L |
2.5-7.5 |
|
Creatinine |
72 µmol/L |
40-90 |
|
CRP |
230 mg/L |
<10 |
|
Urinalysis |
No abnormality detected |
|
|
Chest X-Ray |
Clear |
|
The admitting team commences daily intravenous ceftriaxone 1gm and azithromycin 500mg with a provisional diagnosis of sepsis of unknown origin.
The rest of the viva focussed on antimicrobial prescribing.
The college clearly wanted you to criticise the choice of antibiotics as inappropriate. The agents chosen are for community acquired pneumonia.
If this was really PUO, the current Sanford gide recommendations are to use broad spectrum drugs early, (see under "Sepsis, adult") . The "non-neutropenic adult with clinical syndrome comaptible with bacterial infection" is supposed to get meropenem and vancomycin.
The candidate should be able to debate the possible sources of infection here, which caould be numerous. Of these the most likely is the old line. The PICC should be mentioned at some stage.
Good gram-positive cover should be discussed.
Specifically, the candidate needs to specify doses.
The specific dose of Vancomycin is 30mg/kg
Specific to source control
Specific to sepsis
Audits of blood culture results have revealed a series of organisms which almost always represent a true systemic bacteraemia or fungaemia:
True pathogens:
The correct answer would include a caution to trust the culture (rather than dismissing it immediately as a contaminant).
There are a couple:
Differential time to positivity
Number of positive culture sets
Source control clearly has not been achieved. The patient is likely bacteraemic from another source. The candidate should begin thinking about investigating the patient for other possible sources. If they do not start thinking in this fashion...
An excellent review article form 2009 lists the following clinical features:
These Duke criteria were proposed in 1994 on the basis of an analysis of 405 consecutive cases of infective endocarditis. In order to qualify for IE, one must have either
A major limitation of this set of criteria is the fact that up to 20% of patients have "culture-negative" IE and end up being misclassified. Particularly, patients with Q-fever endocarditis would grow nothing in their cultures, and their diagnosis would be delayed. Some have used this to call for an inclusion of Q-fever serology among the major criteria.
Disclaimer: the viva stem above may be an original CICM stem, acquired from their publicly available past papers. Or, perhaps it is a slightly altered version of the original CICM stem. Or, it is a completely original viva stem, concocted by the monstrously amoral author of Deranged Physiology for nothing more than his own personal amusement. In either case, because the college do not make the main viva text or marking criteria available, almost everything here has been confabulated. It might sound like a plausible viva and it could be used for the purpose of practice, but all should be aware that it does not represent the "true" canonical CICM viva station.
De Leon, Samuel Ponce, and Richard P. Wenzel. "Hospital-acquired bloodstream infections with Staphylococcus epidermidis: review of 100 cases."The American journal of medicine 77.4 (1984): 639-644.
Haslett, T. M., et al. "Microbiology of indwelling central intravascular catheters."Journal of clinical microbiology 26.4 (1988): 696-701.
Stohl, Sheldon, et al. "Blood cultures at central line insertion in the intensive care unit: comparison with peripheral venipuncture." Journal of clinical microbiology 49.7 (2011): 2398-2403.
Beekmann, Susan E., Daniel J. Diekema, and Gary V. Doern. "Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures." Infection control and hospital epidemiology 26.6 (2005): 559-566.
Raad, Issam, et al. "Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia."Infection control and hospital epidemiology (1992): 215-221.
Raad, Issam, et al. "Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?."Clinical infectious diseases 49.8 (2009): 1187-94.
Raad, Issam, et al. "Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections." Annals of Internal Medicine 140.1 (2004): 18-25.
Chu, Vivian H., et al. "Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis." Clinical infectious diseases 46.2 (2008): 232-242.
Blot, François, et al. "Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis." Journal of clinical microbiology 36.1 (1998): 105-109.
DesJardin, Jeffrey A., et al. "Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer."Annals of internal medicine 131.9 (1999): 641-647.
Hall, Keri K., and Jason A. Lyman. "Updated review of blood culture contamination." Clinical microbiology reviews 19.4 (2006): 788-802.
Bates, David W., Lee Goldman, and Thomas H. Lee. "Contaminant blood cultures and resource utilization: the true consequences of false-positive results." JAMA 265.3 (1991): 365-369.
Souvenir, David, et al. "Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients." Journal of clinical microbiology 36.7 (1998): 1923-1926.
Bates, David W., and Thomas H. Lee. "Rapid classification of positive blood cultures: prospective validation of a multivariate algorithm." Jama 267.14 (1992): 1962-1966.
Weinstein, Melvin P., et al. "The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults." Clinical Infectious Diseases 24.4 (1997): 584-602.
Gowardman, J. R., et al. "Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients." Intensive care medicine 24.10 (1998): 1034-1039.
Beekmann, Susan E., Daniel J. Diekema, and Gary V. Doern. "Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures." Infection Control 26.06 (2005): 559-566.
Tokars, Jerome I. "Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance." Clinical infectious diseases 39.3 (2004): 333-341.
Murdoch, David R., et al. "Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study." Archives of internal medicine 169.5 (2009): 463-473.
Richardson, JAMES V., et al. "Treatment of infective endocarditis: a 10-year comparative analysis." Circulation 58.4 (1978): 589-597.
Windsor, HARRY M., and MARK X. Shanahan. "Emergency valve replacement in bacterial endocarditis." Thorax 22.1 (1967): 25-33.
Yu, Victor L., et al. "Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only." The Annals of thoracic surgery 58.4 (1994): 1073-1077.
Brandenburg, Robert O., et al. "Infective endocarditis—a 25 year overview of diagnosis and therapy." Journal of the American College of Cardiology 1.1 (1983): 280-291.
Pruitt, R. D. "William Osler and his Gulstonian Lectures on malignant endocarditis." Mayo Clinic Proceedings. Vol. 57. No. 1. 1982.
Kang, Duk-Hyun, et al. "Early surgery versus conventional treatment for infective endocarditis." New England Journal of Medicine 366.26 (2012): 2466-2473.
Thuny, Franck, et al. "Management of infective endocarditis: challenges and perspectives." The Lancet 379.9819 (2012): 965-975.